Clinical Research Directory
Browse clinical research sites, groups, and studies.
Bladder Cancer Screening Trial
Sponsor: University of Texas Southwestern Medical Center
Summary
There is currently no accepted screening strategy for patients at high risk of developing bladder cancer. This study will ask patients to complete a urine test every 6 months for 2 years to help assess if routine screening helps finding bladder cancer at an earlier stage.
Official title: Optimal Screening Strategy for Bladder Cancer in at Risk Patients
Key Details
Gender
All
Age Range
50 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1000
Start Date
2023-05-05
Completion Date
2028-04
Last Updated
2025-04-13
Healthy Volunteers
No
Interventions
Urinalysis
Urine analysis (every 6 months for 2 years); Patients with \<3 red blood cells (RBCs) per high-powered field (HPF) will repeat screening at 6-month intervals for an average of 2 years. If RBCs are 3-25 RBSc/HPF- subjects will undergo- \[cystoscopy + Upper tract imaging\] or \[urine marker cancer testing with Cxbladder triage + Upper tract imaging\]. If \>25 RBCs, subjects will get - \[cystoscopy + Upper tract imaging\].
Locations (1)
University of Texas Southwestern Medical Center
Dallas, Texas, United States